Gotemba, Japan

Yuki Noguchi


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuki Noguchi: Innovator in Cartilage Tissue Research

Introduction

Yuki Noguchi is a prominent inventor based in Gotemba, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that target cartilage tissue. His innovative work has the potential to enhance therapeutic approaches for conditions affecting cartilage.

Latest Patents

Yuki Noguchi holds a patent for a polypeptide comprising an aggrecan binding domain and a carrying moiety. This invention provides a polypeptide that binds to an antigen present in cartilage tissue, facilitating the retention of desired substances within the cartilage for extended periods. The polypeptide includes an antigen binding domain that interacts with cartilage molecules and a carrying moiety designed to prolong its half-life compared to the antigen binding domain alone. This advancement is crucial for developing pharmaceutical compositions aimed at treating cartilage-related ailments.

Career Highlights

Throughout his career, Yuki Noguchi has demonstrated a commitment to advancing medical science through his research and inventions. His work has garnered attention for its potential applications in regenerative medicine and therapeutic interventions for joint diseases.

Collaborations

Yuki has collaborated with notable colleagues, including Hidetomo Kitamura and Maiko Hoshino. Their combined expertise has contributed to the successful development of innovative solutions in the field of cartilage research.

Conclusion

Yuki Noguchi's contributions to biotechnology, particularly in cartilage tissue research, highlight his role as an influential inventor. His patented polypeptide represents a significant step forward in medical science, offering new possibilities for treating cartilage-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…